INSY
Insys Therapeutics, Inc.
INSY
INSY
Delisted
INSY was delisted on the 18th of June, 2019.
138 hedge funds and large institutions have $592M invested in Insys Therapeutics, Inc. in 2016 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 59 increasing their positions, 38 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
40% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 35
49% less capital invested
Capital invested by funds: $1.15B → $592M (-$558M)
Holders
138
Holding in Top 10
2
Calls
$11.9M
Puts
$12.7M
Top Buyers
| 1 | +$49.4M | |
| 2 | +$9.97M | |
| 3 | +$6.7M | |
| 4 |
Bank of New York Mellon
New York
|
+$5.41M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$4.43M |
Top Sellers
| 1 | -$73.5M | |
| 2 | -$22.3M | |
| 3 | -$19.8M | |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$19.2M |
| 5 |
VM
Valinor Management
New York
|
-$16.8M |